Tambet Teesalu Selected Research

Albumin-Bound Paclitaxel

10/2016	iRGD peptide conjugation potentiates intraperitoneal tumor delivery of paclitaxel with polymersomes.
1/2016	Paclitaxel-Loaded Polymersomes for Enhanced Intraperitoneal Chemotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tambet Teesalu Research Topics

Disease

48	Neoplasms (Cancer) 09/2023 - 04/2003
13	Breast Neoplasms (Breast Cancer) 09/2023 - 07/2015
7	Carcinoma (Carcinomatosis) 01/2021 - 04/2011
7	Glioblastoma (Glioblastoma Multiforme) 01/2021 - 04/2003
6	Peritoneal Neoplasms 05/2018 - 08/2015
5	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2015
5	Prostatic Neoplasms (Prostate Cancer) 04/2016 - 09/2009
3	COVID-19 01/2022 - 11/2020
2	Triple Negative Breast Neoplasms 09/2023 - 04/2018
2	Infections 01/2022 - 02/2018
2	Fetal Growth Retardation (Intrauterine Growth Retardation) 10/2021 - 01/2016
2	Glioma (Gliomas) 01/2021 - 11/2017
2	Atherosclerotic Plaque (Atheroma) 01/2020 - 04/2016
2	Alzheimer Disease (Alzheimer's Disease) 01/2018 - 11/2017
2	Melanoma (Melanoma, Malignant) 11/2017 - 04/2016
2	Neurofibromatosis 2 (Neurofibromatosis Type II) 04/2005 - 10/2003
1	Choroidal Neovascularization 01/2023
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2022
1	Body Weight (Weight, Body) 01/2022
1	Endometriosis 11/2021
1	Hepatocellular Carcinoma (Hepatoma) 10/2021
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021
1	Myocardial Infarction 01/2020
1	Epidermolysis Bullosa Dystrophica (Dystrophic Epidermolysis Bullosa) 01/2020
1	Wounds and Injuries (Trauma) 01/2020
1	Epidermolysis Bullosa 01/2020
1	Multiple Sclerosis 01/2020
1	Fibrosis (Cirrhosis) 01/2020
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2020
1	Staphylococcal Infections 02/2018

Drug/Important Bio-Agent (IBA)

49	Peptides (Polypeptides)IBA 01/2023 - 09/2009
10	Neuropilin-1IBA 01/2022 - 12/2009
8	Proteins (Proteins, Gene)FDA Link 09/2023 - 10/2003
8	LigandsIBA 11/2021 - 04/2016
6	IntegrinsIBA 01/2021 - 12/2009
5	TenascinIBA 11/2021 - 10/2019
5	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2021 - 01/2013
4	DNA (Deoxyribonucleic Acid)IBA 08/2021 - 04/2003
4	N-end cysteine peptide tumor-homing peptideIBA 01/2021 - 01/2013
4	ferric oxide (iron oxide)IBA 01/2020 - 01/2017
3	Paclitaxel (Taxol)FDA LinkGeneric 12/2022 - 01/2016
3	LipidsIBA 12/2022 - 07/2015
3	Liposomes (Liposome)IBA 12/2022 - 01/2016
3	Mannose ReceptorIBA 01/2022 - 11/2017
3	Fibronectins (Fibronectin)IBA 11/2021 - 10/2019
3	AntibodiesIBA 01/2021 - 01/2013
3	SilverIBA 01/2020 - 05/2017
3	Antineoplastic Agents (Antineoplastics)IBA 02/2013 - 12/2009
2	Peptide Receptors (Peptide Receptor)IBA 10/2021 - 04/2016
2	AnthracyclinesIBA 07/2021 - 01/2021
2	AntigensIBA 01/2021 - 08/2013
2	Fluorescein (Funduscein)FDA LinkGeneric 01/2021 - 08/2015
2	Albumin-Bound Paclitaxel FDA Link 10/2016 - 01/2016
2	Peptide Hydrolases (Proteases)FDA Link 01/2016 - 01/2013
2	NeuropilinsIBA 08/2015 - 01/2015
2	Contrast MediaIBA 07/2015 - 01/2013
2	moesinIBA 04/2005 - 10/2003
2	Neurofibromin 2 (Merlin)IBA 04/2005 - 10/2003
2	ezrinIBA 04/2005 - 10/2003
2	radixinIBA 04/2005 - 10/2003
1	Biomarkers (Surrogate Marker)IBA 09/2023
1	Dihydrotachysterol (AT 10)IBA 12/2022
1	Caspase 3 (Caspase-3)IBA 12/2022
1	Oncogene Proteins (Oncogene Protein)IBA 01/2022
1	Prostaglandins AIBA 01/2022
1	Mannose (D-Mannose)IBA 01/2022
1	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 01/2022
1	Threonine (L-Threonine)FDA Link 01/2022
1	Polyglutamic Acid (Polyglutamate)IBA 01/2022
1	Serine (L-Serine)FDA Link 01/2022
1	EnzymesIBA 01/2022
1	CytokinesIBA 01/2022
1	Protein Isoforms (Isoforms)IBA 11/2021
1	Epidermal Growth Factor (EGF)IBA 10/2021
1	resiquimodIBA 10/2021
1	Therapeutic UsesIBA 10/2021
1	mRNA VaccinesIBA 08/2021
1	Nucleic AcidsIBA 08/2021
1	Messenger RNA (mRNA)IBA 08/2021
1	nasIBA 08/2021
1	Small Interfering RNA (siRNA)IBA 08/2021
1	patisiranIBA 08/2021
1	Sorafenib (BAY 43-9006)FDA Link 03/2021
1	peptide AIBA 03/2021
1	Chimeric Antigen ReceptorsIBA 01/2021
1	Atrial Natriuretic Factor (ANF)IBA 01/2020
1	Dextrans (Dextran)FDA Link 01/2020
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2020
1	Peptide LibraryIBA 01/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2019
1	polycaprolactoneIBA 04/2018
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 04/2018
1	Vancomycin FDA LinkGeneric 02/2018

Therapy/Procedure

21	Therapeutics 09/2023 - 05/2010
4	Drug Therapy (Chemotherapy) 12/2022 - 08/2015
2	Lasers (Laser) 01/2023 - 04/2003
2	Precision Medicine 12/2017 - 01/2017
2	Investigational Therapies (Experimental Therapy) 01/2017 - 01/2016
1	Immunomodulation 01/2022
1	Immunotherapy 01/2020